Alcohol and Substance Abuse in Solid-Organ Transplant Recipients

被引:48
|
作者
Parker, Richard [1 ,2 ,3 ]
Armstrong, Matthew J. [1 ,2 ,3 ]
Corbett, Chris [1 ,2 ,3 ]
Day, Edward J. [4 ]
Neuberger, James M. [3 ,5 ]
机构
[1] Univ Birmingham, Natl Inst Hlth Res Biomed Res Unit, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
[4] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
[5] NHS Blood & Transplant, Bristol, Avon, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Alcohol; Drugs; Substance abuse; Transplantation; ORTHOTOPIC LIVER-TRANSPLANTATION; CARBOHYDRATE-DEFICIENT TRANSFERRIN; LONG-TERM GRAFT; ETHYL GLUCURONIDE; FOLLOW-UP; PSYCHOSOCIAL EVALUATION; INTERNATIONAL-SOCIETY; HEART-TRANSPLANTATION; LABORATORY MARKERS; SCREENING-TEST;
D O I
10.1097/TP.0b013e31829f7579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review focuses on alcohol and substance abuse in the context of solid-organ transplantation. Alcohol and substance abuse are common and may lead to a need for solid-organ transplantation and may also contribute to significant physical and psychologic problems that impact upon the recipient. Damaging levels of alcohol intake can occur in the absence of dependence. Alcohol or substance abuse after transplantation is associated with poor medication compliance and this may increase risk of graft loss. Intravenous drug use is associated with increased risk of infections (especially secondary to opportunistic organisms-bacterial, viral, protozoal, and others-and such infections may be more severe in the immunosuppressed), but there is only anecdotal evidence that such behavior has a worse outcome in transplant recipients. Whereas previous alcohol excess and drug use in kidney recipients are both associated with a small but statistically significantly increased risk of adverse outcomes (hazard ratio, 1.16-1.56), alcohol use within recommended guidelines after transplantation appears safe and possibly beneficial. Robust data are lacking for other organs, but those available suggest that heart transplantation is safe in individuals with a history of alcohol or substance abuse. Health specialists in drug or alcohol addiction should carefully screen all potential transplant candidates for these conditions, and where there is evidence of dependency or abuse, effective psychologic and physical treatment should be offered. Studies have shown that interventions such as psychologic intervention have improved alcohol behavior in the context of liver transplantation. Although there are no comparable studies with other solid-organ recipients, it is reasonable to expect transferable outcomes.
引用
收藏
页码:1015 / 1024
页数:10
相关论文
共 50 条
  • [41] Mortality Predictors of Bloodstream Infections in Solid-Organ Transplant Recipients
    Wan, Qiquan
    Ye, Qifa
    Zhou, Jiandang
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (03) : 211 - 214
  • [42] Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients
    Wu, Xuemei
    Venkataramanan, Raman
    Rivosecchi, Ryan M.
    Tang, Chenxiao
    Marini, Rachel, V
    Shields, Ryan K.
    Clancy, Cornelius J.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (02)
  • [43] Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients
    Saha, D. C.
    Goldman, D. L.
    Shao, X.
    Casadevall, A.
    Husain, S.
    Limaye, A. P.
    Lyon, M.
    Somani, J.
    Pursell, K.
    Pruett, T. L.
    Singh, N.
    CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (12) : 1550 - 1554
  • [44] Specialty clinics for the dermatologic care of solid-organ transplant recipients
    Christenson, LJ
    Geusau, A
    Ferrandiz, C
    Brown, CD
    Ulrich, C
    Stockfleth, E
    Berg, D
    Orengo, I
    Shaw, JC
    Carucci, JA
    Euvrard, S
    Pacheco, T
    Stasko, T
    Otley, CC
    DERMATOLOGIC SURGERY, 2004, 30 (04) : 598 - 603
  • [45] Deep cutaneous fungal infections in solid-organ transplant recipients
    Galezowski, Agnes
    Delyon, Julie
    Le Cleach, Laurence
    Guegan, Sarah
    Ducroux, Emilie
    Alanio, Alexandre
    Lastennet, Diane
    Moguelet, Philippe
    Dadban, Ali
    Leccia, Marie Therese
    Le Pelletier, Francois
    Frances, Camille
    Lebbe, Celeste
    Barete, Stephane
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) : 455 - 462
  • [46] Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients
    Falagas, M. E.
    Vardakas, K. Z.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (07) : 603 - 605
  • [47] Endoscopic Resection of Gastric Neoplasm in Solid-Organ Transplant Recipients
    Na, Shin
    Lee, Gin Hyug
    Song, Ju Hyung
    Ahn, Ji Yong
    Kim, Seon-Ok
    Park, Se Jeong
    Park, So-Eun
    Kim, Mi-Young
    Lee, JeongHoon
    Choi, Kwi-Sook
    Kim, Do Hoon
    Song, Ho June
    Choi, Kee Don
    Jung, Hwoon-Yong
    Kim, Jin-Ho
    TRANSPLANTATION, 2014, 97 (07) : 781 - 787
  • [48] Sun protection attitudes and behaviors of solid-organ transplant recipients
    Robinson, JK
    Rigel, DS
    DERMATOLOGIC SURGERY, 2004, 30 (04) : 610 - 615
  • [49] Schistosomiasis and Strongyloidiasis Recommendations for Solid-Organ Transplant Recipients and Donors
    Camargo, Luis Fernando A.
    Kamar, Nassim
    Gotuzzo, Eduardo
    Wright, Alissa Jade
    TRANSPLANTATION, 2018, 102 (02) : S27 - S34
  • [50] International travel and exposure risks in solid-organ transplant recipients
    Uslan, Daniel Z.
    Patel, Robin
    Virk, Abinash
    TRANSPLANTATION, 2008, 86 (03) : 407 - 412